Antioxidants as therapeutic aAgents in acute respiratory distress syndrome (ARDS) treatment - from mice to men

  • Acute respiratory distress syndrome (ARDS) is a major cause of patient mortality in intensive care units (ICUs) worldwide. Considering that no causative treatment but only symptomatic care is available, it is obvious that there is a high unmet medical need for a new therapeutic concept. One reason for a missing etiologic therapy strategy is the multifactorial origin of ARDS, which leads to a large heterogeneity of patients. This review summarizes the various kinds of ARDS onset with a special focus on the role of reactive oxygen species (ROS), which are generally linked to ARDS development and progression. Taking a closer look at the data which already have been established in mouse models, this review finally proposes the translation of these results on successful antioxidant use in a personalized approach to the ICU patient as a potential adjuvant to standard ARDS treatment.

Download full text files

Export metadata

Metadaten
Author:Andreas von KnethenORCiDGND, Ulrike Elisabeth Brigitte HeinickeGND, Volker LauxORCiD, Michael J. ParnhamORCiDGND, Andrea U. SteinbickerORCiDGND, Kai ZacharowskiORCiDGND
URN:urn:nbn:de:hebis:30:3-825027
DOI:https://doi.org/10.3390/biomedicines10010098
ISSN:2227-9059
Parent Title (English):Biomedicines
Publisher:MDPI
Place of publication:Basel
Document Type:Article
Language:English
Date of Publication (online):2022/01/04
Date of first Publication:2022/01/04
Publishing Institution:Universitätsbibliothek Johann Christian Senckenberg
Release Date:2024/02/27
Tag:ARDS; GSH; NADPH oxidase; Nrf2; SOD; antioxidant; electron transfer chain
Volume:10
Issue:1, art. 98
Article Number:98
Page Number:24
First Page:1
Last Page:24
Institutes:Medizin
Dewey Decimal Classification:6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit
Sammlungen:Universitätspublikationen
Licence (German):License LogoCreative Commons - CC BY - Namensnennung 4.0 International